Non‐alcoholic steatohepatitis: another disease of affluence

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285

Nonalcoholic Steatohepatitis

Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.

Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191

Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease

Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,138

Nonalcoholic steatohepatitis: An expanded clinical entity

Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander‐Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,137

The natural history of nonalcoholic fatty liver: A follow-up study

Teli, M. R., James, O., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 913

Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis

Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M. G., & Diehl, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2557 · Cited by 818

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

Weltman, M., Farrell, G. C., Hall, P. D. L. Μ., Ingelman‐Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 613

Hepatic steatosis: Innocent bystander or guilty party?

Day, C. P., & James, O. (1998) · Hepatology · doi:10.1002/hep.510270601 · Cited by 395

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance

James, O., & Day, C. P. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80073-1 · Cited by 370

Unexplained inflammation in end‐stage kidney disease: Is the combination of enhanced gastrointestinal permeability and reticuloendothelial dysfunction its cause?

Swift, O., Vilar, E., & Farrington, K. (2019) · Seminars in Dialysis · doi:10.1111/sdi.12810 · Cited by 8

Relationships Among C-Reactive Protein, Alanine Aminotransferase, and Metabolic Syndrome in Apparently Healthy Chinese Subjects

Huang, H.-H., Chen, Y., Chen, J.-S., Lin, J., Hsieh, C., Pei, D., & Wu, C. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0059 · Cited by 7

Callophyllis japonicaextract improves high-fat diet-induced obesity and inhibits adipogenesis in 3T3-L1 cells

Kang, S., Shin, H., Kim, H.-M., Yoon, S., Kang, S.-W., Ko, H., & Kim, S. (2012) · Animal Cells and Systems · doi:10.1080/19768354.2012.734257 · Cited by 7

Inflammation is associated with liver function markers, independent of other metabolic risk factors in overweight women

Browning, L. M., Krebs, J. D., Siervo, M., Hall, R. M., Finer, N., Allison, M., & Jebb, S. A. (2008) · The British Journal of Diabetes · doi:10.1177/14746514080080020401 · Cited by 7

Reply

Dixon, J. B., O’Brien, P. E., & Bhathal, P. S. (2002) · Gastroenterology · doi:10.1016/s0016-5085(02)80152-4 · Cited by 7

Oxidative Stress in Alcoholic and Nonalcoholic Liver Disease

Domenici, F., & Vannucchi, H. (2014) · CRC Press eBooks · doi:10.1201/b16653-16 · Cited by 6

Latest developments in the imaging of fibrotic liver disease

Sangwaiya, M. J., Sherman, D., Lomas, D. J., & Shorvon, P. J. (2013) · Acta Radiologica · doi:10.1177/0284185113510159 · Cited by 6

Involvement of orexin in lipid accumulation in the liver

Mochizuki, A., Nakayama, K., Nakamura, S., Dantsuji, M., Kamijo, R., Shioda, S., Sakurai, T., Ozeki, M., & Inoue, T. (2018) · Journal of Oral Biosciences · doi:10.1016/j.job.2018.07.001 · Cited by 5

Current biochemical studies of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) suggest a new therapeutic approach Lin Hz, Yang SQ, Chuckaree C, et al., Metformin's Reverses Fatty Liver Disease in Obese Leptin-Deficient Mice, Nature Medicine 2000;6(8):998–1003

Hookman, P. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05998-1 · Cited by 5

Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.

Oakes, N. D., Ljung, B., & Camejo, G. (2002) · Europe PMC (PubMed Central) · Cited by 5

Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients Takashi NakaharaHideyuki HyogoMasato YonedaYoshio SumidaYuichiro EguchiHideki Fujii • Masafumi OnoTakumi KawaguchiKento ImajoHiroshi AikataSaiyu TanakaKazuyuki Kanemasa • Kazuma FujimotoKeizo AnzaiToshiji SaibaraMichio SataAtushi NakajimaYoshito Itoh • Kazuaki ChayamaTakeshi OkanoueJapan Study Group of Nonalcoholic Fatty Liver …

Nakahara, T., Aikata, H., Chayama, K., Imajo, K., Nakajima, A., Yoneda, M., Itoh, S. Y., Eguchi, Y., Fujii, H., Ono, M., et al. (2014) · Cited by 4

The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis

Renno, A. W., Abdel‐Aziz, Y., Alastal, Y., Khuder, S., Hasan, S., Assaly, R., & Nawras, A. T. (2021) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2021.104488 · Cited by 4

Predictors of Nonalcoholic Steatohepatitis in Japanese Patients: Thioredoxin and NASH

Okanoue, T., Yamauchi, N., Furutani, M., Hirohama, A., Sumida, Y., & Nakashima, T. (2005) · doi:10.1007/4-431-27172-4_5 · Cited by 4

Simultaneous liver, pancreas-duodenum and kidney transplantation in a patient with hepatitis B cirrhosis, uremia and insulin dependent diabetes mellitus

Li, J., Guo, Q., Cai, J.-Z., Pan, C., Shen, Z., & Jiang, W. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i45.8104 · Cited by 4

Current biochemical studies of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) suggest a new therapeutic approach. Lin Hz, Yang SQ, Chuckaree C, et al., Metformin's Reverses Fatty Liver Disease in Obese Leptin-Deficient Mice, Nature Medicine 2000;6(8):998-1003

Hookman, P., & Barkin, J. S. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07276.x · Cited by 4

Aspectos clínico-patológicos del hígado graso no alcohólico

Lorenzo, M. P., Estrada, S., Lay, R. W., & Pérez, O. A. (2003) · Cited by 3

Non-Alcoholic Fatty Liver Disease and Malignancy as Complications of Insulin Resistance

Bloomgarden, Z. T. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.316 · Cited by 3

El paciente con hipertransaminasemia

Martínez, H. Á., & Pérez‐Campos, E. (2005) · Cited by 3

Non-alcoholic steatohepatitis

Krentz, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(05)76072-4 · Cited by 3

Clinicopathological analysis of non‐alcoholic steatohepatitis

Ni, Y., Liu, H., Dechang, H., Zhe, W., & Li, M. (2001) · Chinese Journal of Digestive Diseases · doi:10.1046/j.1443-9573.2001.00054.x · Cited by 2

Esteatohepatitis no alcohólica

López, É. M., Domı́nguez-Rosales, J. A., Nazará, Z., & Cerda, A. P. (2005) · Investigación en Salud · Cited by 2

Inhibitory Effects of Solanum lycopersicum L. on High Fat Diet- Induced Fatty Liver Disease in Rats

Mohajeri, D., & Sefidan, A. M. (2013) · Cited by 2

Effects of tomato pulp on hepatic steatosis in the rats fed with high fat diet

Mohajeri, D., & Monadi, A. (2015) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2015_135 · Cited by 2

The Liver in Metabolic Syndrome

D’Amore, S., Palasciano, G., & Moschetta, A. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_3 · Cited by 2

Hepato‐biliary and Pancreatic Function

Masclee, A., & van Hoek, B. (2004) · Wiley eBooks · doi:10.1002/0470013877.ch7 · Cited by 2

Esteato-hepatite relacionada ao vírus da hepatite C: perfil clínico-histológico

Pereira, J. E. D. S., Cotrim, H. P., de Freitas, L. A. R., Paraná, R., Portugal, M., & Lyra, L. G. C. (2006) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442006000200008 · Cited by 2

Non-alcoholic steatohepatitis

Knobler, H., & Schattner, A. (1999) · The Lancet · doi:10.1016/s0140-6736(05)76068-2 · Cited by 2

Developmental Programming of Nonalcoholic Fatty Liver Disease (NAFLD)

Bruce, K. D., & Cagampang, F. R. A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6386-7_12 · Cited by 1

Regulation of Iron Metabolism in NAFLD/NASH

Hamada, Y., & Hirano, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.107221 · Cited by 1

Relationship between Bright Pancreas without Fatty Liver and Lifestyle-Associated Disease at Health Check-up

Hamaguchi, M., Kojima, T., Nakagawa, T., Taniguchi, H., Fujii, K., OMATSU, T., Okuda, J., Ida, K., Watanabe, K., Iwama, M., et al. (2004) · Health Evaluation and Promotion · doi:10.7143/jhep.31.701 · Cited by 1

Association of Fatty Liver and Hypothyroidism

Rahman, S., Al‐Mahtab, M., & Alam, M. J. (2013) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1052 · Cited by 1

QUANTIFICAÇÃO DE MASTÓCITOS EM LESÕES REVERSÍVEIS E IRREVERSÍVEIS DO FÍGADO HUMANO

Paulo, B. E. D., & Rocha, L. B. (2019) · Arquivos de Ciências da Saúde da UNIPAR · doi:10.25110/arqsaude.v23i2.2019.6790 · Cited by 1

Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis

Kang, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100998 · Cited by 1

EFFECT OF ORAL SUPPLEMENTATION OF WHEY PROTEIN ISOLATE ON NON-ALCOHOLIC STEATOHEPATITIS PATIENTS

Tienboon, P., Chitapanarux, T., Pojchamarnwiputh, S., & Donrawee (2009) · Cited by 1

The Metabolic Syndrome, Oxidative Stress, and the Liver

Almeda‐Valdés, P., Aguilar-Olivos, N. E., Uribe, M., & Méndez‐Sánchez, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00025-4 · Cited by 1

CARDIOPROTECTIVE POTENTIAL OF QUERCETIN AGAINST DIESEL OR PETROL EXHAUST NANOPARTICLE INDUCED TOXICITY: A PROSPECTIVE IN VITRO PHARMACOLOGICAL STUDY IN H9C2 CELLS

Mohan, D., & Devasena, T. (2021) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2021.v14i4.40858 · Cited by 1

Non Alcoholic Steathohepatitis (NASH)

(2006) · Springer eBooks · doi:10.1007/1-4020-3840-2_34 · Cited by 1

Insulin Resistance in Clinical Medicine

Krentz, A. J. (2002) · Wiley eBooks · doi:10.1002/9780470698921.ch2 · Cited by 1

Iron, hepatitis C virus and hepatic steatosis

Herruzo, J. A. S., & Solís‐Muñoz, P. (2004) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082004001200001 · Cited by 1

Endorgansch�den bei Fettstoffwechselst�rungen

Faust, M., & Krone, W. (2003) · Der Internist · doi:10.1007/s00108-003-0954-0 · Cited by 1

Non-alcoholic steatohepatitis: potential causes and pathogenic mechanisms

Gerbes, A., Beuers, U. H., Pape, G., Sackmann, M. F., Sauerbruch, T., & Innere, A. (2000) · Cited by 1

Dyslipidemia in Nonalcoholic Fatty Liver Disease: The Composition and Source of Lipids in Triacylglycerol-Rich Lipoproteins and High-Density Lipoproteins

Langreck, E. R. (2011) · Cited by 1

Metabolic disorders and storage diseases

Kuntz, E., & Kuntz, H.-D. (2002) · Springer eBooks · doi:10.1007/978-3-662-04680-7_31 · Cited by 1

Pre-, Pro-, and Synbiotics in Clinical Enteral Nutrition

Bengmark, S. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0379-7.50026-7 · Cited by 1

Peroxisome proliferator-activated receptors (PPARs) and mitochondria in relation to lifestyle-related diseases

Røst, T. H. (2008) · NORA - Norwegian Open Research Archives

Non-alcoholic steatohepatitis: clinical, laboratory, histopathologic evaluation and search for mutations in the HFE gene. Casuistic from a reference center

Deguti, M. M. (2001) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652001000100014

Serum Advanced Glycation End Products Associated with NASH and Other Liver Diseases

Hyogo, H., Yamagishi, S., & Tazuma, S. (2009) · doi:10.1002/9783527628100.ch23

Estrés quirúrgico durante el bypass gástrico en obesos mórbidos

Déniz, J. R. (2010) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)

Varón de 72 años, afectado de diabetes mellitus, con episodios recurrentes de hipoglucemia

Conget, I., Castellví, J., & Álvarez-Castells, A. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)73684-7

EffEct of oral supplEmEntation of unDEnaturED cYstEinE ricH wHEY protEin isolatE on non-alcoHolic stEatoHEpatitis patiEnts

Tienboon, P., & Chitapanarux, T. (2009)

NONALCOHOLIC FATTY LIVER DISEASE: THE MOST COMMONLY OCCURING LIVER DISEASE

Duman, D., & Tozun, N. A. (2004)

Characterization of the role of CD14 in human and animal liver diseases

Leicester, K. L. (2004) · UWA Profiles and Research Repository (University of Western Australia)

Immunological and molecular mechanisms in NAFLD

Copaci, I., Micu, L., Chiriac, G., Mindrut, E., Ismail, G., & Leurzeanu, L. (2015) · Journal of Translational Medicine and Research · doi:10.21614/jtmr-20-4-57

EFFECTS OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON SERUM AMINOTRANSFERASE LEVELS AND INSULIN RESISTANCE

Hamid, M. S., Froutan, H., Nader, F., Naghan, P. A., Andrabi, Y., Mohsen, N. T., & Mohamad, K. (2011) · Medical Journal of the Islamic Republic of Iran

La stéato-hépatite non alcoolique (NASH) : une entité clinique en expansion

Lombardo, F. P., & Marre, M. (2004) · Sciences des Aliments · doi:10.3166/sda.24.3-8

Nutraceutical and Functional Food Application to Nonalcoholic Steatohepatitis

Volker, D. H., & Yunianingtias, D. (2006) · Modern nutrition · doi:10.1201/9781420006186.ch26

Reduction in Systolic Blood Pressure is Associated with Improvements in Metabolic Health in a Model of Diet Induced Obesity

Lee, A. Y.-P. (2016) · eScholarship (California Digital Library)

Steatosis in non alcoholic fatty liver disease

Levene, A. (2012) · Spiral (Imperial College London) · doi:10.25560/9691

Diagnostic, pronostic et possibilités thérapeutiques de la stéatose hépatique non alcoolique

Oneta, C., & Dufour, J. (2003) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2003.04971

Glutathione Ameliorates Mouse Steatohepatitis

Cai, Q. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.29.004851

Impact of Maternal Inflammatory Conditions on the Expression of Drug Transporters

Ghoneim, R. H. (2016) · TSpace (University of Toronto)

Metabolic disorders and storage diseases

(2006) · Springer eBooks · doi:10.1007/3-540-28977-1_31

Storage solutions

Walenbergh, S. M. A. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160129sw

Influencia de la nicotinamida en la síntesis de ácidos grasos de novo en hígado graso: participación de la glucosa -6- fosfato deshidrogenasa

Mejía, S. Á. (2018) · doi:10.24275/uami.sx61dm359

Efecto de una dieta hipercolesterolémica en la regulación de la NADPH oxidasa mediada por HGF-c-MET

Reyes, A. G. L. (2015) · doi:10.24275/uami.9g54xh72b

Nutritional support in alcoholic liver disease: practical management and future strategies

Sherman, D., & WATSON, R. R. (2002) · CRC Press eBooks · doi:10.3109/9780203301388-38

Afriplex GRTTM extract attenuates hepatic steatosis in an in vitro model of NAFLD

Gabuza, K., Mabuda, T. I., Patel, O., Khuboni, N., van Aarde, R., Riedel, S., Sangweni, N. F., Windvogel, S. L., Johnson, R., & Muller, C. J. F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297572

De la microflore intestinale aux maladies hépatiques

Cunningham, S. (2011) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:14865

Prevalence and Risk Factors of Celiac Disease in Patients With Non‐Alcoholic Fatty Liver Disease: A Meta‐Analysis

Keetha, N. R., Rashidian, P., Fleischman, M., Mohammadyari, F., Ulrich, M. T., Hashemi, S. M., Balivada, K. S., Karimi, M. A., Letafatkar, N., Amini‐Salehi, E., et al. (2026) · JGH Open · doi:10.1002/jgh3.70434

Tamoxifen-Induced Nonalcoholic Steatohepatitis

Saibara, T., Ogawa, Y., Xu, N., Nemoto, Y., Ono, M., Wakatsuki, A., Toda, K., Enzan, H., & Onishi, S. (2003) · Springer eBooks · doi:10.1007/978-4-431-67005-6_11

Non-Alcoholic Steatohepatitis and GB Virus-C/Hepatitis G Virus Infection: Is There a Causal Relationship?

Kiyosawa, K. (1997) · Internal Medicine · doi:10.2169/internalmedicine.36.236 · Cited by 5

Non-alcoholic Steatohepatitis

James, O. (2002) · Medicine · doi:10.1383/medc.30.12.62.28524 · Cited by 47

Non‐alcoholic steatohepatitis (NASH): where are we now and where are we going?

Day, C. P. (2002) · Gut · doi:10.1136/gut.50.5.585 · Cited by 181

Non-alcoholic steatohepatitis (NASH) and chronic hepatitis C

Pérez-Carreras, M., Castellano, G., Rivas, E., Colina, F., Álvarez, V., Tomás, E., Fuertes, A., & Solis-Herruzo, J. A. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)80543-8 · Cited by 1

Nonalcoholic steatohepatitis (NASH) as diagnostic problem

Dutkiewicz, E., Kryczka, W., Urbaniak, A., Pabjan, P., & Kubicka, J. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)81067-2